sofwave collagen loss face glp-1 weight loss Exclusive Reclaim Your Confidence Post-GLP-1 Weight

Our patients don't need ideological debates

Ozempic is officieel bedoeld voor de behandeling van type 2 diabetes, maar kan als bijkomend effect gewichtsverlies geven

In January 2025, the FDA approved an injectable form of semaglutide (Ozempic) specifically for managing chronic kidney disease in type 2 diabetes patients

The study analyzed 1,364 patients, including mixed-BMI and obese-only groups, uncovering how factors like weight gain, aging, and gender amplify sleep apnea severity

In the SURPASS-2 trial, patients on tirzepatide 15mg lost 13.1% body weight compared to 6.7% with semaglutidenearly double the loss

INFORMATION What is Retatrutide (60 mg)